drugset
Drugs / CD19.CAR-aNKT cells
last change Jun 2025 re-read 3 minutes ago

CD19.CAR-aNKT cells

also known as ANCHOR cells
Developed for
adult acute lymphoblastic leukemia · chronic lymphocytic leukemia/small lymphocytic lymphoma
Investigated by
Baylor College of Medicine · Center for Cell and Gene Therapy, Baylor College of Medicine · National Cancer Institute (NCI) · The Methodist Hospital Research Institute

Trials 1

today NCT03774654 · Ph 1
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03774654 Apr 2020 → Jun 2025 overdue adult acute lymphoblastic leukemia, chronic lymphocytic leukemia/small lymphocytic lymphoma Baylor College of Medicine Active not recruiting No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD19.CAR-aNKT cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT03774654 ↗
Known as ANCHOR cells “These cells are called ANCHOR cells.” NCT03774654 ↗
Route Intravenous “by intravenous injection (into the vein through an IV line)” NCT03774654 ↗